Skip to main navigation Skip to search Skip to main content

Phase Ill, open-label, single-dose, multi-center multinational trial investigating a serotype 5 adeno-associated viral vector containing the Padua variant of a codon-optimized human factor IX gene (AA VS-hFIXco-Padua, AMT-061) administered

Project: Research

Project Details

StatusFinished
Effective start/end date05/1/19 → 12/31/23

Funding

  • uniQure Biopharma BV: $59,648.00